Medical News

RSS

St. Jude Medical receives European approval for Fortify ST ICD and Unify CRT-D defibrillators

St. Jude Medical, Inc. today announced European CE Mark approval and first implants of its Fortify™ and Fortify ST implantable cardioverter defibrillators (ICD) and Unify™ cardiac resynchronization therapy defibrillator (CRT-D). The devices will be fully launched in Europe later this spring, and U.S. versions of the Fortify ICD and Unify CRT-D are expected to be launched later this year. The reduced size of these new devices compared to those of previous generations creates the smallest available device footprint in the industry.

5 Feb 2010

Sequenom CMM launches SensiGene Fetal RHD Genotyping test for pregnant RhD negative women

Sequenom, Inc. today announced the launch of the SensiGene™ Fetal RHD Genotyping test by Sequenom's CAP accredited and CLIA-certified laboratory, Sequenom Center for Molecular Medicine (Sequenom CMM).

5 Feb 2010

Arrayit's VIP DNA testing technology receives patent protection in Israel

Arrayit Corporation, a life sciences and healthcare technology leader, announced today that the Company has received patent protection in the State of Israel for its proprietary Variation Identification Platform™ (VIP™) DNA testing technology. The Israeli patent extends Arrayit's current patent portfolio, which includes VIP patents in the United States, Singapore, New Zealand, China, South Korea, and the European Union.

5 Feb 2010

Pfizer, DxS sign agreement to develop a diagnostic test kit for CDX-110 to treat patients with GBM

Pfizer Inc. and DxS (a wholly owned subsidiary of QIAGEN N.V.) today announced that they have entered into an agreement to develop a companion diagnostic test kit for PF-04948568 (CDX-110), an immunotherapy vaccine in development for the treatment of glioblastoma multiforme (GBM).

5 Feb 2010

Indiana medical school cuts number of students amid budget cuts

The Louisville Courier-Journal: "Facing a $7 million budget cut, the Indiana University School of Medicine plans to reduce the number of new students next year -- a move that will save money but could reduce the number of physicians when the state is already facing a shortage. After several years of ramping up acceptances of new medical students, IU was forced to cut back after Gov. Mitch Daniels recently ordered state-funded universities to reduce their budgets, said Dr. D. Craig Brater, dean of the school.

5 Feb 2010

Paloma Pharmaceuticals receives FDA approval to enter Phase I studies with P529

Paloma Pharmaceuticals, Inc. announced today that it has received acceptance of its IND to enter Phase I studies with Palomid 529 (P529) in patients with age-related macular degeneration (AMD).

5 Feb 2010

Polymedco's automated immunoassay fecal occult blood test system receives FDA clearance

Polymedco, Inc. today announced that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance of the OC-Sensor Diana, a high throughput automated system for the immunoassay fecal occult blood test (FIT) used for detecting gastrointestinal bleeding associated with disorders such as colorectal cancer, polyps and colitis.

5 Feb 2010

PSKW & Associates purchases Triax Media

PSKW & Associates LLC of Edison, New Jersey, which owns the Loyalty Rx Co-pay Card, has purchased Triax Media LLC of Irvine, California. At the same time, PSKW has licensed the purchase to its subsidiary, Centricity Group LLC of Mendham, New Jersey.

5 Feb 2010

Lux Biosciences seeks US and European marketing approval for LUVENIQ

Lux Biosciences, Inc. today announced its submission of simultaneous regulatory filings to both the U.S. Food and Drug Administration (FDA) and European Medicines Agency (EMA) seeking marketing approval for its investigational drug LUVENIQ™ (LX211; oral voclosporin) for the treatment of noninfectious uveitis involving the intermediate or posterior segments of the eye.

5 Feb 2010

Majority of rural hospital stays are covered by Medicare

Medicare patients accounted for almost half of all stays (45 percent) at rural hospitals in 2007, while the percentage of Medicare beneficiaries who were admitted to urban hospitals was considerably lower (35 percent) , according to the latest News and Numbers from the Agency for Healthcare Research and Quality.

5 Feb 2010

Progenics Pharmaceuticals to present preclinical data of multiplex PI3K inhibitors

Progenics Pharmaceuticals, Inc. today announced the presentation of preclinical data on a series of novel compounds that simultaneously blocked two critical pathways involved in the growth and survival of cancer cells.

4 Feb 2010

Michael J. Fox Foundation announces more than $2.8M in awards to discover biomarkers of PD

The Michael J. Fox Foundation for Parkinson's Research today announced more than $2.8 million in awards for 13 new projects to speed the discovery of biomarkers of PD.

4 Feb 2010

ASTRO and ACR release practice guidelines for new radiation treatments

The American Society for Radiation Oncology (ASTRO) and the American College of Radiology (ACR) have released practice guidelines for image guided radiation therapy (IGRT) and stereotactic body radiation therapy (SBRT) in the February issue of the International Journal of Radiation Oncology*Biology*Physics, the official journal of ASTRO.

4 Feb 2010

House to move forward to end antitrust exemption for health insurers

"House Democratic leaders are moving forward with Plan B for passing health care reform by introducing a stand-alone measure to strip the antitrust exemption for health insurance companies — a popular piece of their stalled health care reform package," Roll Call reports. "Freshmen Reps. Tom Perriello (D-Va.) and Betsy Markey (D-Colo.) will file legislation on Friday aimed at barring the insurance industry from fixing prices and setting their own markets without being investigated.

4 Feb 2010

Lux Biosciences files NDA with FDA and MAA with EMA for approval of voclosporin

Isotechnika Pharma Inc. today announced that its partner, Lux Biosciences, Inc., has filed a New Drug Application (NDA) with the U.S. Food and Drug Administration (FDA) and a Market Authorization Application (MAA) with the European Medicines Agency (EMA) for voclosporin, under the proposed brand name, LUVENIQ(TM).

4 Feb 2010

Global cancer rates could be reduced by 40% with prevention strategies, report says

"Forty percent of the 12 million people diagnosed with cancer worldwide each year could avert the killer disease by protecting themselves against infections and changing their lifestyles, experts said on Tuesday," Reuters reports.

4 Feb 2010

FDA approves first laser treatment for stretch marks

Palomar Medical Technologies, Inc. is pleased to announce that the Lux1540™ Fractional non-ablative laser handpiece has received the first clearance by the United States Food and Drug Administration (FDA) for the treatment of striae (stretch marks) using a fractional laser. This new clearance will allow aesthetic practitioners to treat the millions of women worldwide who have unwanted stretch marks.

4 Feb 2010

Allergan acquires Serica Technologies

Morningside Technology Ventures, Prism VentureWorks, and Ivy Capital Partners are pleased to announce the acquisition of their portfolio company, Serica Technologies, Inc. by Allergan, Inc. Serica is a growth-stage medical device company focused on the development of biodegradable silk-based scaffolds for use in tissue regeneration in numerous therapeutic areas. Following the acquisition, Serica became a wholly owned subsidiary of Allergan.

4 Feb 2010

Health spending consumes more of U.S. economy, will tip toward government

A new report by federal actuaries shows government programs will pay for more than half of all U.S. health care spending by 2012, and that total spending on health grew as a share of the economy by 1.1 percent last year to 17.3 percent, the largest leap ever, the Los Angeles Times reports.

4 Feb 2010

Obama tries to bridge Democratic divide on health reform

Speaking with Senate Democrats Wednesday, President Obama "suggested that Republicans could be enlisted to play at least some role in negotiating a final bill, The Washington Post reports.

4 Feb 2010

Medical News

St. Jude Medical receives European approval for Fortify ST ICD and Unify CRT-D defibrillators

Sequenom CMM launches SensiGene Fetal RHD Genotyping test for pregnant RhD negative women

Arrayit's VIP DNA testing technology receives patent protection in Israel

Pfizer, DxS sign agreement to develop a diagnostic test kit for CDX-110 to treat patients with GBM

Indiana medical school cuts number of students amid budget cuts

Paloma Pharmaceuticals receives FDA approval to enter Phase I studies with P529

Polymedco's automated immunoassay fecal occult blood test system receives FDA clearance

PSKW & Associates purchases Triax Media

Lux Biosciences seeks US and European marketing approval for LUVENIQ

Majority of rural hospital stays are covered by Medicare

Progenics Pharmaceuticals to present preclinical data of multiplex PI3K inhibitors

Michael J. Fox Foundation announces more than $2.8M in awards to discover biomarkers of PD

ASTRO and ACR release practice guidelines for new radiation treatments

House to move forward to end antitrust exemption for health insurers

Lux Biosciences files NDA with FDA and MAA with EMA for approval of voclosporin

Global cancer rates could be reduced by 40% with prevention strategies, report says

FDA approves first laser treatment for stretch marks

Allergan acquires Serica Technologies

Health spending consumes more of U.S. economy, will tip toward government

Obama tries to bridge Democratic divide on health reform

Bioprocess Efficiency with Cell Density Monitoring

Exploring electron microscopy for plant and microbial imaging at the John Innes Centre

Extending the reach of Amperia™

Latest News